Pablo Lapuerta, MD

Pablo Lapuerta, MD is a physician and biotech executive. In 2021, he founded 4M Therapeutics, a biotech company with scientific founders from Harvard and MIT.

4M Therapeutics is discovering new medicines with the potential to help brain cells survive and connect to each other more effectively. The hope is to someday provide new options for the treatment of bipolar disorder, depression, traumatic brain injury, and Alzheimer’s disease.

Dr. Lapuerta previously served as Chief Medical Officer at Lexicon Pharmaceuticals and Vice President of Clinical Development at Bristol-Myers Squibb. His work has contributed to several drug approvals, and he authored over 100 scientific publications, including four studies in the New England Journal of Medicine.

Dr. Lapuerta graduated from Keystone in 1981. He earned his AB in Biology summa cum laude from Harvard College in 1985 and his MD from Harvard Medical School in 1989. He completed a residency in internal medicine at UNC Chapel Hill and a post-doctoral research fellowship in neuroscience at UCLA.